Netherlands· NL-fb5ed9e9ffd8
Vancomycin Hikma 500 mg, Poeder voor concentraat voor oplossing voor infusie
A vancomycin product containing vancomycine + vancomycinehydrochloride, registered in Netherlands by Hikma Farmaceutica (Portugal), S.A.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Vancomycin is registered in 11 of 19 countries.
Countries holding a registration under ATC J01XA01 (vancomycin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Vancomycin · ATC J01XA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of vancomycin costs, country by country.
Normalised to the WHO defined daily dose (2 g), the median price runs from $0.068 in Finland to $96.70 in Switzerland — a ×1424 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vancomycin · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$96.70
- FI Finland$0.068
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- VANCOMYCINE + VANCOMYCINEHYDROCHLORIDE
- Manufacturer
- Hikma Farmaceutica (Portugal), S.A.
- Country
- Netherlands (NL)
- ATC code
- J01XA01
- ATC class
- Vancomycin
- Defined daily dose
- 2 g, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id110475
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
533 interactions on record for vancomycin.
Graded by severity as the source publishes them — 23 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Vancomycin · interactions on record
533 records
- 23 severe
- 99 moderate
- 411 info
Most severe, free to view
- PiperacillinJ01CA12severe
- Piperacillin und Beta-Lactamase-InhibitorJ01CR05severe
- CidofovirJ05AB12severe
- Humane Immunglobuline, unspezifisch, extravaskulärJ06BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Vancomycin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesTYZAVANHikma Pharmaceuticals USA Inc.
- United KingdomVancocin 1g powder for solution for infusion vialsFlynn Pharma Ltd
- CzechiaCEDEPOSHeaton k.s., Praha
- FinlandNorimkoNRIM Limited
- CanadaJAMP VANCOMYCINJAMP PHARMA CORPORATION
- GermanyVanco-SaarMip Pharma Gmbh
- BelgiumVamysin 1000 mgTeva Pharma Belgium
- PolandEdicinSandoz GmbH
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Vancocin, Vancomycin Aptapharma
- Belgium · Vancomycine Fresenius Kabi, Vancomycine Sandoz
- Bulgaria · Vancocin Cp, Ванко-Вм
- Cyprus · Vanco, Vanco Sapiens
- Czechia · Cedepos, Edicin
- Germany · Vanco-Saar, Vancomycin "lederle"
- Denmark · Bactocin, Vancocin
- Estonia · Vancomycin Kabi, Vancosan
- Spain · Vancomicina Mip, Vancomicina Noridem
- Finland · Vancomycin Bioglan, Vancomycin Bioglan 500 Mg Pulver Till Koncentrat Till Infusionsvätska, Lösning
- France · Vancomycine Hikma, Vancomycine Kabi
- United Kingdom (Northern Ireland) · Vancocin, Vancocin Matrigel
- Greece · Lyovanco, Vancomycin Noridem
- Croatia · Edicin, Vancomicin Viatris
- Hungary · Vancocin, Vancomycin Aptapharma
- Ireland · Vancocin, Vancocin Matrigel
- Iceland · Vancomycin Fresenius Kabi, Vancomycin Hameln
- Italy · Levovanox, Maxivanil
- Lithuania · Vancomycin Ibe, Vancomycin Kabi
- Luxembourg · Vancomycin Enterocaps, Vancomycine
- Latvia · Vancomycin Kabi, Vancosan
- Malta · Cedepos, Vancomycin Aptapharma
- Norway · Vancomycin Fresenius Kabi, Vancomycin Hameln
- Poland · Edicin, Vancomicina Reig Jofre
- Portugal · Vancomicina Azevedos, Vancomicina Generis
- Romania · Cedepos, Vancomicină Aptapharma
- Sweden · Vancocin, Vancomycin Bioglan
- Slovenia · Edicin, Vancomycin Viatris
- Slovakia · Cedepos, Edicin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e2cd3985-e3a2-45e2-b61d-de7eed2483d1 GET /v1/drugs/e2cd3985-e3a2-45e2-b61d-de7eed2483d1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder voor concentraat voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h110475_smpc.pdf",
"strength": null,
"atc_label": "Vancomycin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg110475",
"excipients": [
"STIKSTOF (HEAD SPACE) (E 941)"
],
"substances": [
"VANCOMYCINE",
"VANCOMYCINEHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h110475.pdf",
"authorised_at": "2013/05/08",
"procedure_number": "PT/H/0771/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "110475",
"additional_monitoring": "N"
}See everything about vancomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.